LONDON, April 27, 2021 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative gene therapies for patients suffering from inherited systemic debilitating diseases, today announced that the Company will give six poster presentations at the American Society of Gene and Cell Therapy Annual Meeting 2021, taking place May 11 – 14.

More:
Freeline to Present Data at the American Society of Gene and Cell Therapy Annual Meeting 2021

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh